Clinical Trial Update: GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma [NA]

View source ↗

Summary

The study investigates whether GATA6 expression can predict response to peri-operative chemotherapy in resectable pancreatic cancer, with the trial currently li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Resectable Pancreatic Cancer | NA | Status: ACTIVE_NOT_RECRUITING